These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32212135)

  • 1. The Lingering Questions in Immunotherapy.
    Wright K
    Oncology (Williston Park); 2020 Mar; 34(3):. PubMed ID: 32212135
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy combinations in advanced nonsmall cell lung cancer.
    Pirker R
    Curr Opin Oncol; 2021 Jan; 33(1):73-79. PubMed ID: 33186185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update.
    Abdel-Rahman O; Morris D
    Immunotherapy; 2019 Feb; 11(3):149-153. PubMed ID: 30730273
    [No Abstract]   [Full Text] [Related]  

  • 5. Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy.
    Daly ME
    J Clin Oncol; 2022 Feb; 40(6):539-545. PubMed ID: 34985921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant immunotherapy in nonsmall cell lung cancer.
    Pall G
    Curr Opin Oncol; 2021 Jan; 33(1):59-63. PubMed ID: 33229874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward innovative combinational immunotherapy: A systems biology perspective.
    Li XT; Yang JJ; Wu YL; Hou J
    Cancer Treat Rev; 2018 Jul; 68():1-8. PubMed ID: 29775845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
    Gkolfinopoulos S; Mountzios G
    Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?
    Rassy E; Mezquita L; Remon J; Besse B
    Immunotherapy; 2019 Sep; 11(13):1149-1160. PubMed ID: 31361172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
    Wang ZM; Song Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. There and back again: An immunotherapy tale.
    Guo Y; Krupnick AS
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1771-1774. PubMed ID: 29409610
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy combinations emerging in non-small-cell lung cancer.
    Chao YL; Pecot CV
    Immunotherapy; 2018 Jun; 10(8):627-629. PubMed ID: 29882690
    [No Abstract]   [Full Text] [Related]  

  • 13. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies.
    Wu Y; Yu G; Jin K; Qian J
    Front Immunol; 2024; 15():1349502. PubMed ID: 39015563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options after first-line immunotherapy in metastatic NSCLC.
    Santos ES
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):221-228. PubMed ID: 32141356
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer.
    Uprety D
    Clin Lung Cancer; 2019 Mar; 20(2):63-65. PubMed ID: 30545572
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune-based Therapies for Non-small Cell Lung Cancer.
    Rafei H; El-Bahesh E; Finianos A; Nassereddine S; Tabbara I
    Anticancer Res; 2017 Feb; 37(2):377-387. PubMed ID: 28179283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immunotherapy in stage III nonsmall cell lung cancer.
    Wrona A
    Curr Opin Oncol; 2019 Jan; 31(1):18-23. PubMed ID: 30489337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
    Qiao M; Jiang T; Ren S; Zhou C
    Clin Lung Cancer; 2018 Jan; 19(1):1-11. PubMed ID: 28716463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in patients with early stage resectable nonsmall cell lung cancer.
    Ghysen K; Vansteenkiste J
    Curr Opin Oncol; 2019 Jan; 31(1):13-17. PubMed ID: 30325753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directions.
    Custodio A; de Castro J
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):338-60. PubMed ID: 21908201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.